Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Muscle Tissue

Explore clinical trials studying Neoplasms, Muscle Tissue. Study availability and eligibility vary by location and protocol.

606 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Muscle Tissue trial results

Completed

Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

NCT00562471

Conditions
Cicatrix, Fibrosis, Myoma, +7 more
Locations
  • St. Joseph's Health Centre Toronto, Ontario, Canada
  • Klinik für Minimal Invasive Chirurgie Berlin, Germany
  • Universitätsklinikum Giessen Giessen, Germany
  • Univ. Clinics of Schleswig-Holstein Kiel, Germany
View Trial Details
Active, Not Recruiting

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

NCT04337177

Conditions
Disease Attributes, Ewing Sarcoma, Glioma, +26 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • UCSF, Mission Bay - Benioff Children's Hospital San Francisco, California, United States
  • Children's National Research Institute - Children's National Hospital Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital Atlanta, Georgia, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma

NCT04994132

Conditions
Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, +14 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Kingman Regional Medical Center Kingman, Arizona, United States
View all 250 locations
View Trial Details
Active, Not Recruiting

Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

NCT03155620

Conditions
Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +99 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 172 locations
View Trial Details

Related conditions